Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926236-07-000026
Filing Date
2007-04-02
Accepted
2007-04-02 16:21:28
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K YEAR ENDED DECEMBER 31, 2006 cli06q4.txt 10-K 305842
2 FORM OF CERTIFICATE FOR COMMON STOCK exh4-1.txt EX-4.1 6724
3 SUBSIDIARIES exh21-1.txt EX-21.1 863
4 CONSENT exh23-1.txt EX-23.1 1544
5 CONSENT exh23-2.txt EX-23.2 1523
6 RULE 13A-14(A) CERTIFICATION exh31-1.txt EX-31.1 3515
7 RULE 13A-14(A) CERTIFICATION exh31-2.txt EX-31.2 3560
8 SECTION 906 CERTIFICATION exh32-1.txt EX-32.1 1469
9 SECTION 906 CERTIFICATION exh32-2.txt EX-32.2 1449
  Complete submission text file 0000926236-07-000026.txt   327970
Mailing Address 2001 WALNUT HILL LANE IRVING TX 75038
Business Address 2001 WALNUT HILL LANE IRVING TX 75038 972-518-1300
CARRINGTON LABORATORIES INC /TX/ (Filer) CIK: 0000718007 (see all company filings)

EIN.: 751435663 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10862 | Film No.: 07739293
SIC: 2834 Pharmaceutical Preparations